RB

Reetu Bhatia

Director Director DIN 03030247
DIN 03030247 First appointment May 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2010
Shareholding value •••• Premium profile

About Reetu Bhatia

Data last updated:

Reetu Bhatia was a Director at Mits Healthcare Private Limited (2010–2021) and Director at Mits Life Sciences Private Limited (2016–2022). The companies operate in Pharma.

DIN 03030247
Primary Designation Director
Industry Pharma
First Appointment 28 May 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mits Healthcare Private Limited U74999UP2010PTC040798
Director28 May 20102010₹26.04 Cr (FY 2024)Active
Mits Life Sciences Private Limited U93000CH2016PTC041301
Director14 Dec 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mits Healthcare Private Limited
Mits Life Sciences Private Limited
Premium access

Shareholding and investment profile for Reetu Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reetu Bhatia

Reetu Bhatia was first appointed on 28 May 2010 as Director at Mits Healthcare Private Limited. The most recent appointment on record is 14 Dec 2016 at Mits Life Sciences Private Limited.

Reetu Bhatia held 2 earlier board appointments: Mits Healthcare Private Limited (Director, 28 May 2010 to 28 Dec 2021); Mits Life Sciences Private Limited (Director, 14 Dec 2016 to 09 May 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available